SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies, invites investors to review audio and written transcripts of a recent investor conference call in which Dr. Stephen Chang, Chief Executive Officer of MultiCell, discussed recent events and progress.
